Pages that link to "Q41756957"
Jump to navigation
Jump to search
The following pages link to Fish oil and glycemic control in diabetes. A meta-analysis (Q41756957):
Displaying 50 items.
- Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus (Q24242688) (← links)
- Omega 3 fatty acid for the prevention of dementia (Q24244723) (← links)
- Omega 3 fatty acid for the prevention of dementia (Q24246716) (← links)
- Insulin and insulin resistance. (Q24532776) (← links)
- A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease (Q26829277) (← links)
- Omega-3 fatty acids in the treatment of psychiatric disorders (Q28251943) (← links)
- Genetic variants at PSMD3 interact with dietary fat and carbohydrate to modulate insulin resistance (Q28282981) (← links)
- An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia (Q28362661) (← links)
- Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids (Q28728625) (← links)
- Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium (Q30431111) (← links)
- n-3 polyunsaturated fatty acid supplementation, monocyte adhesion molecule expression and pro-inflammatory mediators in Type 2 diabetes mellitus (Q30651548) (← links)
- Nutrition management and physical activity as treatments for diabetes (Q33752771) (← links)
- N-3 fatty acids from fish and coronary artery disease: implications for public health. (Q33901597) (← links)
- Plasma phospholipid EPA and DHA are divergently associated with overall mortality in newly diagnosed diabetic patients: results from a follow-up of the Nord-Trøndelag Health (HUNT) Study, Norway (Q34126216) (← links)
- Fish consumption, blood docosahexaenoic acid and chronic diseases in Chinese rural populations. (Q34267641) (← links)
- SREBF1 gene variations modulate insulin sensitivity in response to a fish oil supplementation (Q34333647) (← links)
- Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes (Q34404267) (← links)
- Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis (Q34415945) (← links)
- Algal Docosahexaenoic Acid Affects Plasma Lipoprotein Particle Size Distribution in Overweight and Obese Adults (Q34493093) (← links)
- Marine n-3 fatty acids: basic features and background (Q34524261) (← links)
- (n-3) Fatty Acids: Clinical Trials in People with Type 2 Diabetes (Q34591917) (← links)
- Nutritional supplements for older adults: review and recommendations--Part II. (Q34618719) (← links)
- Nutrient- and non-nutrient-based natural health product (NHP) use in adults with mood disorders: prevalence, characteristics and potential for exposure to adverse events (Q34660563) (← links)
- Nutrition and diabetes control: advice for non-dietitians. (Q34793894) (← links)
- Evidence for the cardioprotective effects of omega-3 Fatty acids (Q35009466) (← links)
- Plasma omega-3 fatty acids and incident diabetes in older adults (Q35125358) (← links)
- Nutrition therapy for dyslipidemia (Q35219419) (← links)
- The effect of omega-3 on the serum visfatin concentration in patients with type II diabetes (Q35544822) (← links)
- Pharmacotherapy for dyslipidaemia – current therapies and future agents (Q35574960) (← links)
- Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy (Q35674267) (← links)
- Dyslipidemia treatment: current considerations and unmet needs (Q35696526) (← links)
- Fish oils--adjuvant therapy in chronic heart failure? (Q35855345) (← links)
- Pharmacologic treatment of type 2 diabetic dyslipidemia (Q35976827) (← links)
- Fish oil in cardiovascular prevention. (Q36101767) (← links)
- Effect of Early Intervention with Omega-3 on Insulin Resistance in Patients Initiated on Olanzapine with either Sodium Valproate or Lithium: A randomized, Double-blind, Placebo-Controlled Trial (Q36197756) (← links)
- Obesity and lipids (Q36300187) (← links)
- Fish consumption, insulin sensitivity and beta-cell function in the Insulin Resistance Atherosclerosis Study (IRAS) (Q36360809) (← links)
- Plasma α-Linolenic and Long-Chain ω-3 Fatty Acids Are Associated with a Lower Risk of Acute Myocardial Infarction in Singapore Chinese Adults (Q36498035) (← links)
- Complementary and alternative therapies for the management of dyslipidemia (Q36626326) (← links)
- Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. (Q36660439) (← links)
- Limited evidence for effects of diet for type 2 diabetes from systematic reviews (Q36717918) (← links)
- Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance (Q36796125) (← links)
- Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes (Q36836650) (← links)
- Effect of fish oil on circulating adiponectin: a systematic review and meta-analysis of randomized controlled trials (Q36885884) (← links)
- Nutritional management in childhood and adolescent diabetes (Q36938575) (← links)
- Identification of Novel Genetic Determinants of Erythrocyte Membrane Fatty Acid Composition among Greenlanders (Q37036681) (← links)
- Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: a double-blind randomised controlled trial (Q37086913) (← links)
- Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis (Q37098566) (← links)
- Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials (Q37344184) (← links)
- Reduced Glycemic Variability in Diazoxide-Responsive Children with Congenital Hyperinsulinism Using Supplemental Omega-3-Polyunsaturated Fatty Acids; A Pilot Trial with MaxEPA(R.). (Q37634286) (← links)